Bank of Montreal Can Sells 8,359 Shares of Intuitive Surgical, Inc. $ISRG

Bank of Montreal Can decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.7% in the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 472,519 shares of the medical equipment provider’s stock after selling 8,359 shares during the period. Bank of Montreal Can owned 0.13% of Intuitive Surgical worth $211,325,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Tobam grew its position in shares of Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 40 shares in the last quarter. Kilter Group LLC purchased a new position in shares of Intuitive Surgical during the second quarter valued at $27,000. Greykasell Wealth Strategies Inc. bought a new stake in shares of Intuitive Surgical in the third quarter valued at about $27,000. Caitlin John LLC bought a new stake in shares of Intuitive Surgical in the third quarter valued at about $30,000. Finally, Guerra Advisors Inc purchased a new stake in Intuitive Surgical in the third quarter worth about $37,000. Institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In related news, SVP Mark Brosius sold 4,500 shares of the business’s stock in a transaction on Friday, December 12th. The stock was sold at an average price of $547.36, for a total transaction of $2,463,120.00. Following the transaction, the senior vice president directly owned 907 shares in the company, valued at $496,455.52. The trade was a 83.23% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Myriam Curet sold 421 shares of the company’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $208,378.16. Following the transaction, the executive vice president directly owned 409 shares in the company, valued at $202,438.64. This represents a 50.72% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 37,802 shares of company stock valued at $19,945,322. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the stock. Wells Fargo & Company increased their target price on shares of Intuitive Surgical from $600.00 to $654.00 and gave the stock an “overweight” rating in a report on Friday, December 12th. UBS Group set a $570.00 price target on shares of Intuitive Surgical and gave the stock a “neutral” rating in a research report on Tuesday, February 24th. Truist Financial lifted their price objective on shares of Intuitive Surgical from $620.00 to $650.00 and gave the company a “buy” rating in a report on Thursday, December 18th. Sanford C. Bernstein upped their target price on Intuitive Surgical from $740.00 to $750.00 and gave the stock an “outperform” rating in a report on Friday, January 23rd. Finally, Robert W. Baird dropped their target price on Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating on the stock in a research report on Friday, January 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $615.86.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $485.85 on Wednesday. The company’s 50-day simple moving average is $518.26 and its 200-day simple moving average is $512.74. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $603.88. The stock has a market capitalization of $172.54 billion, a P/E ratio of 61.58, a P/E/G ratio of 3.81 and a beta of 1.66.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping the consensus estimate of $2.27 by $0.26. The firm had revenue of $2.87 billion during the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. Intuitive Surgical’s revenue was up 18.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.21 EPS. On average, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.